Old Web
English
Sign In
Acemap
>
authorDetail
>
Sanjay Chandrasekaran
Sanjay Chandrasekaran
Emory University
Cancer research
PI3K/AKT/mTOR pathway
Medicine
Immunotherapy
Pathology
5
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and -γ
2021
Frontiers in Immunology
Sanjay Chandrasekaran
Christopher Ronald Funk
Troy Kleber
Chrystal M. Paulos
Mala Shanmugam
Edmund K. Waller
Show All
Source
Cite
Save
Citations (0)
819 Targeting vasoactive intestinal peptide receptor signaling: a novel approach to enhance anti-tumor response in pancreatic ductal adenocarcinoma
2020
Journal for ImmunoTherapy of Cancer
Sruthi Ravindranathan
Passang Tenzin
Sanjay Chandrasekaran
Brandon Ware
Mohammad Y. Zaidi
Shuhua Wang
Rohan K. Dhamsania
Jingru Zhu
Susan N. Thomas
Anish Majumdar
Gregory B. Lesinski
Bassel F. El-Rayes
Edmund K. Waller
Show All
Source
Cite
Save
Citations (0)
Phosphoinositide 3-kinase signaling can modulate MHC class I and II expression
2019
Molecular Cancer Research
Sanjay Chandrasekaran
Maiko Sasaki
Christopher D. Scharer
Haydn T. Kissick
Dillon G. Patterson
Kelly R. Magliocca
John T. Seykora
Bishu Sapkota
David A. Gutman
Lee A. D. Cooper
Gregory B. Lesinski
Edmund K. Waller
Susan N. Thomas
Sergei V. Kotenko
Jeremy M. Boss
Carlos S. Moreno
Robert A. Swerlick
Brian P. Pollack
Show All
Source
Cite
Save
Citations (16)
Linking MAPK inhibition and the response to TNF in melanoma.
2018
Journal of Clinical Oncology
Sanjay Chandrasekaran
Maiko Sasaki
Brian P. Pollack
Show All
Source
Cite
Save
Citations (0)
Interrogating PI3K to induce PD-L1 expression in oral carcinoma.
2018
Journal of Clinical Oncology
Sanjay Chandrasekaran
Maiko Sasaki
Brian P. Pollack
Show All
Source
Cite
Save
Citations (1)
1